Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial
- Karim Fizazi (Corresponding Author)
- , Neal D Shore
- , Matthew Smith
- , Rodrigo Ramos
- , Robert Jones
- , Günter Niegisch
- , Egils Vjaters
- , Yuan Wang
- , Shankar Srinivasan
- , Toni Sarapohja
- , Frank Verholen
Research output: Contribution to journal › Article › peer-review
12
Citations
(Scopus)
6
Downloads
(Pure)